Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126337481 | 12633748 | 1 | I | 20160627 | 20160727 | 20160808 | 20160808 | EXP | CH-SM-2016-06200 | CH-BAYER-2016-145966 | BAYER | 69.00 | YR | E | F | Y | 0.00000 | 20160808 | OT | CH | CH |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126337481 | 12633748 | 1 | PS | ADEMPAS | RIOCIGUAT | 1 | 1 MG, UNK | 204819 | 1 | MG | TABLET | ||||||||
| 126337481 | 12633748 | 2 | SS | NOVALGIN | METAMIZOLE SODIUM | 1 | 500 MG, 1 DOSE 20-JUN-2016 +/- 2 DAYSX1 DOSE 30-JUN-2016 | Y | 0 | 500 | MG | ||||||||
| 126337481 | 12633748 | 3 | SS | NOVALGIN | METAMIZOLE SODIUM | 1 | Y | 0 | |||||||||||
| 126337481 | 12633748 | 4 | SS | OPSUMIT | MACITENTAN | 1 | UNK | 0 | |||||||||||
| 126337481 | 12633748 | 5 | SS | PANTOZOL | PANTOPRAZOLE SODIUM | 1 | Oral | SINCE AT LEAST 3 YEARS | 0 | ||||||||||
| 126337481 | 12633748 | 6 | SS | IMUREK | AZATHIOPRINE | 1 | Oral | 50 MG, BID | 0 | 50 | MG | BID | |||||||
| 126337481 | 12633748 | 7 | SS | TORASEMIDE | TORSEMIDE | 1 | Oral | 15 MG, QD, SINCE LONGER TIME (}3 MONTHS) | 0 | 15 | MG | QD | |||||||
| 126337481 | 12633748 | 8 | C | REMODULIN | TREPROSTINIL | 1 | Intravenous drip | .0325 ?G/KG, Q1MIN CONTINUOUS INFUSION BY PUMP | 0 | .033 | UG/KG | /min | |||||||
| 126337481 | 12633748 | 9 | C | REMODULIN | TREPROSTINIL | 1 | 0 | ||||||||||||
| 126337481 | 12633748 | 10 | C | MARCOUMAR | PHENPROCOUMON | 1 | PRN BY INR | 0 | 3 | MG | |||||||||
| 126337481 | 12633748 | 11 | C | SPIRICORT | PREDNISOLONE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126337481 | 12633748 | 1 | Pulmonary arterial hypertension |
| 126337481 | 12633748 | 2 | Rheumatic disorder |
| 126337481 | 12633748 | 3 | Arthralgia |
| 126337481 | 12633748 | 4 | Pulmonary arterial hypertension |
| 126337481 | 12633748 | 6 | Interstitial lung disease |
| 126337481 | 12633748 | 8 | Pulmonary arterial hypertension |
| 126337481 | 12633748 | 9 | Interstitial lung disease |
| 126337481 | 12633748 | 11 | Interstitial lung disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126337481 | 12633748 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126337481 | 12633748 | Agranulocytosis | |
| 126337481 | 12633748 | Anaemia macrocytic | |
| 126337481 | 12633748 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126337481 | 12633748 | 1 | 20160614 | 0 | ||
| 126337481 | 12633748 | 4 | 201408 | 0 | ||
| 126337481 | 12633748 | 6 | 201308 | 0 |